Chloroform can cause cancer and developmental toxicity according to an independent committee of scientific and health experts.
Definition
Chloroform can cause cancer and developmental toxicity according to an independent committee of scientific and health experts.
Source: PubChem
US FDA substance register · UNII 7V31YC746X · registered name Chloroform · single chemical substance
Cosmetic roles
Safety & regulatory references
- Banned
- Argentina · ASEAN · Brazil · Canada · China · European Union · Japan · South Korea · Taiwan · United Kingdom · United States
Source: ASEAN Cosmetic Directive · EU Cosmetics Regulation · Health Canada Cosmetic Ingredient Hotlist · Japan Standards for Cosmetics · MFDS (Korea) cosmetic regulatory information · Taiwan FDA cosmetic ingredients · UK cosmetics regulations (OPSS) · US eCFR cosmetics regulations · US FDA prohibited and restricted ingredients
Korea’s toxic-substance GHS classification: Danger · H372 (category 1) · H331 (category 3) · H315 (category 2) · +5 more
EU Cosmetics Regulation, Annex II (prohibited substances), entry 366
Health Canada Cosmetic Ingredient Hotlist · prohibited in cosmetics
Restriction II/366 · Other restriction: ban substances that deplete the ozone layer
Source: EU CosIng ingredient list
More data — names, identifiers, properties, test records, literature
Names & identifiers
- CAS No.chemical registry number
- 67-66-3
- EC No.EU chemical inventory number
- 200-663-8
- DTXSIDUS EPA chemical ID
- DTXSID1020306
- DTXCIDUS EPA compound ID
- DTXCID10306
- IUPAC
- Trichloromethane
- Molecular formula
- CHCl3
- Molecular weight
- 119.37 g/mol
Measured properties
- Appearance
- Chloroform appears as a clear colorless liquid with a characteristic odor. Denser (12.3 lb / gal) than water and slightly soluble in water. Hence sinks in water. Nonflammable under most conditions, but burns under extreme conditions. May cause illness by inhalation, skin absorption or ingestion. Used as a solvent, to make other chemicals, as a fumigant. · Liquid
- Odour
- Pleasant, etheric, nonirritating · Pleasant odor
- Boiling point
- 143 °F at 760 mmHg (EPA, 1998) · 61.12 °C
- Melting point
- -82.3 °F (EPA, 1998) · -63.47 °C
- Solubility
- less than 1 mg/mL at 66 °F (NTP, 1992) · In water, 7.95X10+3 mg/L at 25 °C
- Density
- 1.4832 at 68 °F (EPA, 1998) - Denser than water, will sink · 1.4788 g/cu cm at 25 °C
- Odour threshold
- 3.3 ppm
- Melting/freezing point
- -63.5 ℃
- Initial boiling point and range
- 61.23 ℃(1013 hPa)
- Evaporation rate
- 11.6
- Vapour pressure
- 211 hPa(20℃)
- Water solubility
- 8.7 g/ℓ
- Vapour density
- 4.12
- Relative density
- 1.4788 (g/cu cm at 25℃)
- n-Octanol/water partition coefficient (Kow)
- 1.97 (log Pow, 25℃)
- Auto-ignition temperature
- 600 ℃(1013 hPa)
- Viscosity
- 0.563 cP
- Molecular weight
- 119.378
Values measured on the substance itself. The KOSHA data are a reference for writing and reviewing safety data sheets, not a specification for a commercial raw material.
Source: PubChem · KOSHA safety data sheets (Korea)
What products actually use it for
What the 7 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.
- Solvent2
- Intermediate2
- Processing aids not otherwise specified1
- Chemical reaction regulator1
- Degradant/impurity (EPA)1
Source: US EPA CompTox dashboard
Irritation and sensitisation studies
9 skin studies and 5 eye studies are on record.
The study conclusions largely agree (100%). These tests are on the raw material itself; irritation at the amount in a finished product is a different question.
See all 14 studies
- Classification not possible
Skin Sensitization · Screening - Category 2
Skin Irritation · Screening - Not likely to be sensitizing
skin sensitisation: in vivo (LLNA) · Screening · according to EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay) - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to EU Method B.6 (Skin Sensitisation) - Skin Irrit. 2
Skin Irritation · Authoritative - Skin irritation - category 2
Skin Irritation · Screening - Skin corrosion/irritation - Category 2
Skin Irritation · Screening - Category 6.3A (Category 2)
Skin Irritation · Read Across - Skin Irrit. 2
Skin Irritation · Screening - Category 6.4A (Category 2A)
Eye Irritation · Read Across - Category 1
Eye Irritation · Screening - Eye Irrit. 2
Eye Irritation · Authoritative - Eye irritation - category 2A
Eye Irritation · Screening - Serious eye damage/eye irritation - Category 2
Eye Irritation · Screening
Source: US EPA CompTox dashboard
Related literature
- Chloroform · 2025
- Chloroform skin injury after endodontic Chloroform skin injury after endodontic retreatment: Case report · 2021
- STUDY OF SOME HEALTH EFFECTS IN WORKERS EXPOSED TO CHLOROFORM · 2007
- [Hygienic evaluation of the combined effect of portable water chloroform]. · 2006
- Toxicity of chloroform. · 1998
Linked databases 28
- ASEAN Cosmetic Directive
- Australian Industrial Chemicals Inventory (AICIS)
- ChEBI
- ChEMBL
- EU CosIng ingredient list 2
- EU Cosmetics Regulation
- EU prohibited substances (Annex II)
- Health Canada Cosmetic Ingredient Hotlist
- IARC carcinogen classification
- Japan Standards for Cosmetics
- Korea toxic substances GHS register (NIER)
- KOSHA safety data sheets (Korea)
- MFDS (Korea) cosmetic regulatory information 2 3
- NIST Chemistry WebBook
- PubChem 2
- Taiwan FDA cosmetic ingredients
- Tlooto literature search 2 3 4 5
- UK cosmetics regulations (OPSS)
- UniChem cross-reference IDs
- US eCFR cosmetics regulations
- US EPA CompTox dashboard 2
- US EPA DSSTox chemical database
- US FDA prohibited and restricted ingredients
- US FDA substance registration (GSRS)
- US FDA Unique Ingredient Identifier (UNII)
- US National Toxicology Program reports 2
- Wikidata
- Wikipedia · Korean · English · Japanese · Chinese